Research Affairs

With more than 1900 full-time faculty, $302 million in research awards and more than 500,000 square feet of dedicated research space, IU School of Medicine is well-equipped to take on bold medical research projects that promote groundbreaking scientific discovery while improving health care interventions, patient care and health outcomes.

In the most recent fiscal year, IU School of Medicine received nearly $320 million in total research grants and awards, including $126 million from the National Institutes of Health. Anantha Shekhar, MD, PhD, executive associate dean for Research Affairs, oversees IU School of Medicine’s research enterprise. He also has served as the founding director of the Indiana Clinical and Translational Sciences Institute since 2008.

 

Precision Health Initiative

IU School of Medicine’s Precision Health Initiative is the inaugural recipient of funding through Indiana University’s Grand Challenges Program, which will help IU School of Medicine and its partner institutions understand and optimize the prevention, onset, treatment, progression and health outcomes of human diseases through a more precise definition of the genetic, developmental, behavioral and environmental factors that contribute to an individual’s health. Developed by a team of researchers and physicians led by principal investigator Anantha Shekhar, MD, PhD, this initiative will transform biomedical research, health care innovations and the delivery of health interventions in Indiana. The Precision Health Initiative will receive as much as $40 million in funding from the Grand Challenges Program, along with $80 million invested by IU School of Medicine.

What is the Precision Health Initiative?

The Precision Health Initiative is an ambitious plan that will cure at least one cancer through the development of new cell, gene and immune therapies and develop novel disease-modifying or prevention methods for adult neurodegenerative diseases such as Alzheimer’s Disease. It will also use gene and other therapies to cure at least one genetic pediatric disease. This initiative involves collaboration with industry and community partners, including Eli Lilly and Co., Roche Diagnostics, Cook Regentec, Deloitte, Regenstrief Institute and IU Health.

Learn more about Grand Challenges

 

Transforming Clinical Practices Initiative

IU School of Medicine is one of 29 organizations selected to receive funding as part of the $685 million Transforming Clinical Practices Initiative created by the Centers for Medicare and Medicaid in the US Department of Health and Human Services to drive changes in the practice of medicine—to help clinicians improve health and health care while lowering costs. Given four years and $46.4 million, IU School of Medicine is leading a project to support 11,500 physicians, advance practice providers and clinical pharmacists in Indiana, Illinois and Michigan.

Meet Our Experts

Malaz A. Boustani, MD

Malaz A. Boustani, MD

Richard M. Fairbanks Professor of Aging Research
Dr. Boustani leads the Great Lakes Practice Transformation Network, a coalition of 33 partners including the three states' health departments and eight universities.
Rob Dimmitt

Rob Dimmitt

Director of Research Administration
 

Medical Research Expertise

IU School of Medicine investigators conduct world-class basic, translational and clinical research in a broad range of scientific endeavors. Neuroscience, cancer, musculoskeletal and diabetes/cardiovascular/metabolic disorders have been designated as research priority areas and represent the school’s areas of expertise. Strategic themes within each of those priority areas are precision medicine, population health, cell-based therapy and life-span research.

Always Something New

With more than $300 million in external grants and awards, IU School of Medicine oversees a comprehensive research enterprise guided by the following goals:

  • Grow research funding through focused investment
  • Recruit and retain research leaders, both physicians and research scientists
  • Enhance the health of Indiana and beyond by offering innovative therapies not available elsewhere and being a leader in population health management
  • Accelerate translation of research to the clinic and the marketplace through high-quality clinical trials and public-private partnerships
  • Train future researchers for Indiana and worldwide